Back to History Current Version

How to raise awareness during a pandemic? Evidence from Pakistan

Last registered on October 05, 2020

Pre-Trial

Trial Information

General Information

Title
How to raise awareness during a pandemic? Evidence from Pakistan
RCT ID
AEARCTR-0006555
Initial registration date
October 01, 2020

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
October 02, 2020, 10:52 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
October 05, 2020, 5:18 PM EDT

Last updated is the most recent time when changes to the trial's registration were published.

Locations

Primary Investigator

Affiliation
Università degli Studi di Verona

Other Primary Investigator(s)

PI Affiliation
Center for Evaluation and Development (C4ED)
PI Affiliation
Department of Economics, University of Dortmund
PI Affiliation
University of Mannheim
PI Affiliation
Universität Mannheim, Center for Evaluation and Development
PI Affiliation
Universität Mannheim, Center for Evaluation and Development
PI Affiliation
Center for Evaluation and Development
PI Affiliation
Center for Evaluation and Development

Additional Trial Information

Status
On going
Start date
2020-07-01
End date
2021-03-31
Secondary IDs
Abstract
Public health authorities high-income countries encourage excessive testing as a strategy to break the chain of COVID-19 infections and to identify high risk areas. This strategy, is often unfeasible in several developing countries, such as Pakistan. In this study, we design and test the effectiveness of different awareness campaign strategies aiming at encouraging preventive behaviour during a pandemic where ground mobilisation is limited. The awareness campaign is designed and implemented in close cooperation with two implementing partners, Acted Pakistan and the National Rural Support Programme (NRSP). The target population are beneficiaries of the two NGOs across the three provinces of Pakistan, Khyber Pakhtunkhwa, Punjab, and Sindh. As of early September 2020, contacts of NGO beneficiaries and community representatives (incl. community leaders) were collected in 1147 villages. Out of these, 764 villages were randomized to receive the awareness campaign. The remaining 383 villages serve as control group (with no intervention). The awareness campaign is conducted via two modalities: via phone calls (573 villages) or phone calls and remote mobilisation of local task forces (191 villages). Additionally, individuals in the treatment villages were randomized to receive five different awareness messages via phone calls. The survey is conducted remotely, over the phone. Outcomes at baseline were captured for beneficiaries and community representatives (incl. community leaders). We plan to follow the same individuals over 7 bi-monthly short surveys capturing key main outcomes. The endline survey is planned for December 2020. The main aim of the study is to test the effectiveness of the awareness campaign on knowledge, perceptions, behaviour (labour supply and adherence to preventive measures) as well as health status. In addition, we capture information on intervention delivery (implementation and take-up). The awareness campaign is being launched in the last week of September 2020. While the baseline data for randomization is fixed, we do collect additional refresher contacts in the same villages and also plan to collect a new sample of additional villages to which the study will be extended. Thus, once baseline outcomes and characteristics are retrieved, these contacts will also become part of the eligible pool for the research study.
External Link(s)

Registration Citation

Citation
Avdeenko, Alexandra et al. 2020. "How to raise awareness during a pandemic? Evidence from Pakistan." AEA RCT Registry. October 05. https://doi.org/10.1257/rct.6555-1.1
Sponsors & Partners

Partner

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2020-09-23
Intervention End Date
2020-12-07

Primary Outcomes

Primary Outcomes (end points)
Intermediate outcomes:
1. Main (Intermediate) Awareness : Knowledge Symptoms - % of respondents who correctly report the three common symptoms of COVID-19;
1. Main (Intermediate) Awareness : Knowledge Prevention and response strategies - % of respondents who correctly report the three common preventive measures;
1. Main (Intermediate) Perception : Costs of getting infected - Perceived treatment costs (direct costs and forgone income);
1. Main (Intermediate) Perception : Probability of getting infected - % of respondents who have moderate or high concerns of getting infected;
1. Main (Intermediate) Perception : Probability of infecting others - % of respondents who have moderate or high concerns of infecting household members;
1. Main (Intermediate) Perception : Severity - % of respondents who think that COVID-19 sickness can be severe;

Final outcomes:
1. Main (Final) Behavior: Labor supply - % of respondents who have worked outside home in the past 7 days;
1. Main (Final) Behavior: Labor supply - % of respondents reporting that at least one household member worked outside home in the past 7 days;
1. Main (Final) Behavior: Labor supply - # of hours respondent worked per-day outside home;
1. Main (Final) Behavior: Prevention - % of respondents practicing the three common preventive measures;
1. Main (Final) Behavior: Social interactions - % of respondent who received any visits in the past 7 days;
1. Main (Final) Health: COVID-like symptoms - # of household members falling sick with COVID-19 like symptoms in the last 14 days;

Take-up:
1. Main Take up: General Assumptions: Understanding - % of respondents that correctly answered knowledge question about the additional awareness message delivered in the information session;
1. Main Take up: General Assumptions: Understanding - # of correctly answered knowledge questions about the basic awareness message delivered in the information session;
1. Main Take up: Take up: Basic Message - % of respondents reporting that they have received the awareness treatment (basic message);
1. Main Take up: Take up: LHTF - % of respondents reporting that they were exposed to the LHTF intervention [scale];
1. Main Take up: Take up: Specific Message - % of respondents reporting that they have received the awareness treatment (additional message) [scale];
Primary Outcomes (explanation)
Knowledge about COVID-19, perceptions (likelihood of getting infected, infecting others, severity of sickness and costs), mobility (within and outside village), prevention, social interactions, labor supply outside home and health status, take-up.

Secondary Outcomes

Secondary Outcomes (end points)
Intermediate:
2. Secondary (Intermediate) Awareness : Knowledge Any - % of respondents who have heard of COVID-19;
2. Secondary (Intermediate) Awareness : Knowledge Prevention and response strategies - # of correctly reported emergency measures if suspecting an infection;
2. Secondary (Intermediate) Awareness : Knowledge Transmission Channels - # of correctly answered questions about the transmission of the corona virus [scale];
2. Secondary (Intermediate) Awareness : Knowledge Symptoms - % of respondents indicating that they know the COVID-19 symptoms;
2. Secondary (Intermediate) Awareness : Misconceptions - % of respondents who are aware that spiritual and traditional healers can not treat a COVID-19 infection;
2. Secondary (Intermediate) Awareness : Misconceptions - # of misconceptions related to the COVID-19, correctly identified by respondents [scale];
2. Secondary (Intermediate) Awareness : Misconceptions - % of respondents who are aware that older population is particularly endangered by the COVID-19;
2. Secondary (Intermediate) Perception : Costs of getting infected - Perceived cost for being ill for one week;
2. Secondary (Intermediate) Perception : Costs of getting infected - Perceived number of weeks required until recovery ;
2. Secondary (Intermediate) Perception : Influence on getting infected - % of respondents reporting that their behavior can influence somewhat to a great extent the probablity of infection;


Final outcomes:
2. Secondary (Final) Behavior: Labor supply - # of days respondent worked outside home in the past 7 days;
2. Secondary (Final) Behavior: Labor supply - # of days on average other household members worked outside home in the past 7 days;
2. Secondary (Final) Behavior: Mobility Work - # of days respondent left the village in the past 7 days for work;
2. Secondary (Final) Behavior: Mobility Leisure - % of respondents who have left their village in the past 7 days for leisure ;
2. Secondary (Final) Behavior: Mobility Work- % of respondents who have left their village in the past 7 days for work;
2. Secondary (Final) Behavior: Mobility - # of days respondents stayed at home in the past 7 days without going out at all;
2. Secondary (Final) Behavior: Mobility Work - # of days other household members left the village in the past 7 days for work;
2. Secondary (Final) Behavior: Mobility- % of respondents reporting that other household members have left the village in the past 7 days for work ;
2. Secondary (Final) Behavior: Prevention - % of individuals wearing mask when leaving home in past 7 days;
2. Secondary (Final) Behavior: Prevention - # of occasions respondents wash their hands with soap and water during the day;
2. Secondary (Final) Behavior: Prevention - % of respondents changing religious practices as a prevention measure;
2. Secondary (Final) Behavior: Social interactions - % of respondents who have gone to the mosque or church in the past 7 days;
2. Secondary (Final) Behavior: Social interactions - % of respondents who have attended a social gathering in the past 7 days;
2. Secondary (Final) Behavior: Social interactions - % of respondents reporting that at least one household member has attended a social gathering in the past 7 days;
2. Secondary (Final) Behavior: Social interactions - # of days respondents did not restrict social contact in the past 7 days;
2. Secondary (Final) Health: General health - % of respondents reporting bad current health status;
2. Secondary (Final) Health: General health - % of household members falling sick in last 14 days;
2. Secondary (Final) Health: General health - # of village residents falling seriously ill in the last 14 days ;
2. Secondary (Final) Health: Mortality - # of village residents who have died in the last 14 days;

Take-up
2. Secondary Take up: General Assumptions: Access to utilities - % of respondents reporting that they have access to masks;
Secondary Outcomes (explanation)
Knowledge about COVID-19 virus, misconceptions, perceptions (cost of getting infected, own behavior influence), prevention, mobility, social interactions, labour supply, health, take-up.
2. Secondary Take up: General Assumptions: Access to utilities - % of respondents reporting that they have access to masks

Experimental Design

Experimental Design
We conduct an RCT with ten treatment arms (excluding the control group). The RCT is designed to evaluate two different strategies of conducting remote awareness campaigns for NGO beneficiaries. The first one consists in an awareness campaign over the phone and the second one is awareness campaign over the phone accompanied by awareness via a local health task force (LHTF) team mobilized over the phone but conducting awareness activities on the ground(e.g. awareness via posters, loudspeakers). We followed a two-stage randomization process.
First, we stratify the prioritized universe of revenue villages by the implementing partner. In each stratum, 33% of revenue villages were assigned to control, and 67% to treatment. Among the treated villages, 75% were assigned to receive awareness campaign over the phone, while 25% were assigned to receive the awareness campaign over the phone and – in addition – via the LHTF.
Secondly, treated individuals were randomized to receive five different awareness treatments about COVID-19 over the phone: basic awareness(t0); basic awareness + additional message on the potential severity of sickness (t1); basic awareness + additional message on the potential likelihood of contracting COVID-19 (t2); basic awareness + additional message on the potential likelihood of infecting others (t3); basic awareness + additional message on the potential cost of contracting COVID-19 (t4).
While the baseline data for randomization is fixed, we do collect additional refresher contacts in the same villages and also plan to collect a new sample of additional villages to which the study will be extended.
The same experimental design will be applied.
Experimental Design Details
We conduct an RCT with ten treatment arms (excluding the control group). The RCT is designed to evaluate two different strategies of conducting remote awareness campaigns for NGO beneficiaries. The first one consists in an awareness campaign over the phone and the second one is awareness campaign over the phone accompanied by awareness via a local health task force (LHTF) team mobilized over the phone but conducting awareness activities on the ground(e.g. awareness via posters, loudspeakers). We followed a two-stage randomization process.
First, we stratify the prioritized universe of revenue villages by the implementing partner. In each stratum, 33% of revenue villages were assigned to control, and 67% to treatment. Among the treated villages, 75% were assigned to receive awareness campaign over the phone, while 25% were assigned to receive the awareness campaign over the phone and – in addition – via the LHTF.
Secondly, treated individuals were randomized to receive five different awareness treatments about COVID-19 over the phone: basic awareness(t0); basic awareness + additional message on the potential severity of sickness (t1); basic awareness + additional message on the potential likelihood of contracting COVID-19 (t2); basic awareness + additional message on the potential likelihood of infecting others (t3); basic awareness + additional message on the potential cost of contracting COVID-19 (t4).
While the baseline data for randomization is fixed, we do collect additional refresher contacts in the same villages and also plan to collect a new sample of additional villages to which the study will be extended.
The same experimental design will be applied.
Randomization Method
We apply the procedure outlined above for randomization. In each stage, we apply a re-randomization procedure incorporating multivariate balance checks.


In order to allow us to test the null hypothesis that the treatment effect is zero (or any other value) and to calculate confidence intervals we will apply randomization inference.
To reduce the number of tests in our analysis, we pool primary outcomes that are similar in the sense that they are expected to be proxies of the same underlying behavior and test the same hypotheses or sub-hypotheses. Details on this and other strategies to adjust for multiple hypothesis testing are presented in the PAP.
Randomization Unit
Randomization at revenue village (RVs) and individual level.
Was the treatment clustered?
Yes

Experiment Characteristics

Sample size: planned number of clusters
1147 villages. A further sample of villages will be added and randomized into the study.
Sample size: planned number of observations
12883 individuals. More individuals will be added and randomized into the study following two upcoming data collection waves.
Sample size (or number of clusters) by treatment arms
Number of clusters (villages) by treatment arms




treatm_0_IE1 No awareness

Control villages: 383 villages




treatm_1_IE1 Basic awareness

Awareness villages: 110 73.83%
Awareness + LHTF villages: 39 26.17%

Total villages: 149 100%



treatm_2_IE1 + severity of coronavirus

Awareness villages: 110 78.01%
Awareness + LHTF villages: 31 21.99%

Total villages: 141




treatm_3_IE1 + individual's prob of getting infected

Awareness villages: 110 72.37%
Awareness + LHTF villages: 42 27.63%

Total villages: 152




treatm_4_IE1 + HHm's prob of getting infected

Awareness villages: 127 76.97%
Awareness + LHTF villages: 38 23.03%

Total villages: 165




treatm_5_IE1 + cost of health treatment
Awareness villages: 116 73.89%
Awareness + LHTF villages: 41 26.11%

Total villages: 157
.




Sample size by treatment arm


treatm_0_IE1 No awareness

Control individuals: 4161


treatm_1_IE1 Basic awareness

Awareness individuals: 1,265 72.53 %
Awareness + LHTF individuals: 479 27.46%

Total individuals: 1,744


treatm_2_IE1 + severity of coronavirus

Awareness individuals: 1,265 72.53 %
Awareness + LHTF individuals: 479 27.46%

Total individuals: 1,744



treatm_3_IE1 + individual's prob of getting infected

Awareness individuals: 1,265 72.53 %
Awareness + LHTF individuals: 480 27.52%

Total individuals: 1,745



treatm_4_IE1 + HHm's prob of getting infected

Awareness individuals: 1,265 72.53 %
Awareness + LHTF individuals: 479 27.46%

Total individuals: 1,744



treatm_5_IE1 + cost of health treatment

Awareness villages: 1,266 72.55%
Awareness + LHTF villages: 479 27.45%

Total individuals: 1,745
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
To calculate the base (or pre-treatment) level of all main outcome variables, we used baseline data from the subsample (sample 1) of observations already available at the time of registration. This data was collected from beginning of August until the 3rd week of September and includes 12,883 individual observations. We look at MDEs for three different evaluations: i) any awareness treatment vs. the control group; ii) any awareness treatment + local health task force (LHTF) vs. awareness treatment only; and iii) any awareness treatment + an additional awareness message vs. awareness treatment only. Whereas i) and ii) are implemented at village level, iii) is randomized at individual level. We estimate minimum detectable differences (MDEs) given alpha=0.5 and power=0.8 and consider a conservative scenario in terms of attrition. For treatments which are implemented on village level, we estimate to be left with 6 observations per village at the end of the trial. This equals 37.5% of the observations we are aiming for and thus an attrition rate of 62.5%. For treatments implemented at individual level, we use an attrition rate of 60%. The following MDEs account for the inclusion of control variables. Given the above assumptions, we can detect a relative change from a baseline level of 13.3 percent to an expected level of 15.9-16.6 percent (impact of 19.5-25.8%) for knowledge of the main COVID-19 symptoms, depending on the level of comparison; a relative change from a baseline level of 29.0 percent to an expected level of 32.4-33.5 percent (impact of 11.7-15.4%) for knowledge of the main preventive measures; a relative change from a baseline level of 37.3 percent to an expected level of 41.4-42.7 percent (impact of 10.9-14.5%) for being highly or moderately concerned about getting infected; a relative change from a baseline level of 47.8 percent to an expected level of 52.1-53.5 percent (impact of 9.0-11.8%) for being highly or moderately concerned about infecting others; a change from a baseline level of 12,636.03 Pakistani Rupees (PKR) to an expected level of 15,349,07-16,224.40 PKR (impact of 21.5-28.4%) for the perceived average cost of getting infected; a relative change from a baseline level of 32.4 percent to an expected level of 27.9-29.1 percent (impact of -10.2-14.0%) for having had visits in the previous 7 days; a relative change from a baseline level of 39.4 percent to an expected level of 34.7-35.9 percent (impact of -9.0-11.9%) for having worked outside home in the previous 7 days; a change from a baseline level of 2.62 hours to an expected level of 2.23-2.33 (impact of -11.0-14.9%) for hours worked per day in the previous 7 days; a relative change from a baseline level of 23.3 percent to an expected level of 26.4-27.4 percent (impact of 13.1-17.6%) for practicing all 3 main preventive measures; and a change from a baseline level of 0.1 to an expected level of 0.061-0.078 (impact of -23.2-40.7%) for the amount of people within a household with common corona virus symptoms.
IRB

Institutional Review Boards (IRBs)

IRB Name
Universität Mannheim
IRB Approval Date
2020-05-25
IRB Approval Number
N/A
IRB Name
Institutional Review Board of RESEARCH AND DEVELOPMENT SOLUTIONS, Islamabad, Pakistan
IRB Approval Date
2020-05-15
IRB Approval Number
IRB00010843
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials